Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine
Jian, W., Yamashita, H., Levitt, J. M., Lerner, S. P., Sonpavde, G.Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-09-0141
Date:
July, 2009
File:
PDF, 510 KB
english, 2009